(S)-2-amino-3-(4-iodophenyl)propionamamide | 97964-72-2

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (S)-2-amino-3-(4-iodophenyl)propionamamide
• 英文别名: (S)-2-amino-3-(4-iodophenyl)propanamide；4-iodo-(L)-phenylalaninamide；4-iodophenylalanine amide；(2S)-2-amino-3-(4-iodophenyl)propanamide
• CAS: 97964-72-2
• 化学式: C₉H₁₁IN₂O
• 分子量: 290.104
• InChiKey: AQQGIRLSOBZONA-QMMMGPOBSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  69.1
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (S)-2-amino-3-(4-iodophenyl)propionamamide 在 tris(dibenzylideneacetone)dipalladium (0) sodium tetrahydroborate 、 碘 、 碳酸氢钠 、 三乙胺 作用下， 以 四氢呋喃 、 乙腈 为溶剂， 生成 tert-butyl N-[(2S)-1-[4-[[4-(dimethylamino)phenyl]-[(2-methylpropan-2-yl)oxy]phosphoryl]phenyl]-3-[(2-methylpropan-2-yl)oxycarbonylamino]propan-2-yl]carbamate
  参考文献：
  名称：

  Metal control of non-polar binding shape selectivity

  摘要：

  Ligand 1 forms a hydrophobic cavity upon binding to metals, the shape of which depends on the metal. A reversal in binding preference for naphthalene or biphenyl groups is found when the metal is changed from zinc to copper, with a selectivity change of 260 fold. (C) 1999 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0040-4039(99)01579-8
• 作为产物：
  描述：

  4-iodo-L-phenylalanine 在 氯化亚砜 作用下， 以 甲醇 为溶剂， 生成 (S)-2-amino-3-(4-iodophenyl)propionamamide
  参考文献：
  名称：

  Metal control of non-polar binding shape selectivity

  摘要：

  Ligand 1 forms a hydrophobic cavity upon binding to metals, the shape of which depends on the metal. A reversal in binding preference for naphthalene or biphenyl groups is found when the metal is changed from zinc to copper, with a selectivity change of 260 fold. (C) 1999 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0040-4039(99)01579-8

文献信息

• SUBSTITUTED N- [1-CYANO-2- (PHENYL) ETHYL] -2-AZABICYCLO [2.2.1] HEPTANE-3-CARBOXAMIDE INHIBITORS OF CATHEPSIN C
  申请人：GRUNDL Marc

  公开号：US20130172327A1

  公开（公告）日：2013-07-04

  Disclosed are N-1-cyano-2-(phenyl)ethyl)-2-azabicyclo[2.2.1]heptane-3-carboxamides of formula I and their use as inhibitors of Cathepsin C, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of respiratory diseases.

  公开了式I的N-1-氰基-2-(苯基)乙基)-2-氮杂双环[2.2.1]庚烷-3-羧酰胺，以及它们作为Cathepsin C抑制剂的用途，含有它们的药物组合物，以及将它们用作治疗和/或预防呼吸道疾病的药剂的方法。
• Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
  申请人：ASTRAZENECA AB

  公开号：US09522894B2

  公开（公告）日：2016-12-20

  The present disclosure relates to certain (2S)—N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamide compounds (including pharmaceutically acceptable salts thereof), that inhibit dipeptidyl peptidase 1 (DPP1) activity, to their utility in treating and/or preventing clinical conditions including respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), to their use in therapy, to pharmaceutical compositions containing them and to processes for preparing such compounds.

  本公开涉及特定（2S）-N-[(1S)-1-氰基-2-苯乙基]-1,4-噁唑烷-2-甲酰胺化合物（包括其药用盐），其抑制二肽基肽酶1（DPP1）活性，以及它们在治疗和/或预防包括哮喘和慢性阻塞性肺病（COPD）在内的临床疾病中的用途，它们在治疗中的应用，含有它们的药物组合物以及制备这类化合物的方法。
• CERTAIN (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES AS DIPEPTIDYL PEPTIDASE 1 INHIBITORS
  申请人：ASTRAZENECA AB

  公开号：US20150210655A1

  公开（公告）日：2015-07-30

  The present disclosure relates to certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamide compounds (including pharmaceutically acceptable salts thereof), that inhibit dipeptidyl peptidase 1 (DPP1) activity, to their utility in treating and/or preventing clinical conditions including respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), to their use in therapy, to pharmaceutical compositions containing them and to processes for preparing such compounds.

  本公开涉及某些（2S）-N-[(1S)-1-氰基-2-苯乙基]-1,4-噁唑烷-2-羧酰胺化合物（包括其药用盐），其抑制二肽基肽酶1（DPP1）活性，用于治疗和/或预防包括哮喘和慢性阻塞性肺病（COPD）在内的临床疾病，以及它们在治疗中的用途，含有它们的药物组合物以及制备这类化合物的方法。
• [EN] SUBSTITUTED 1-CYANOETHYLHETEROCYCLYLCARBOXAMIDE COMPOUNDS 750<br/>[FR] COMPOSÉS 1-CYANOÉTHYLHÉTÉROCYCLYLCARBOXAMIDE SUBSTITUÉS 750
  申请人：ASTRAZENECA AB

  公开号：WO2010128324A1

  公开（公告）日：2010-11-11

  The present invention provides compounds of formula (I), in which y, m, n, R1, R2 and Q are as defined in the specification, a process for their preparation, pharmaceutical compositions containing them and their use in therapy.

  本发明提供了式（I）的化合物，其中y、m、n、R1、R2和Q如规范中定义，以及它们的制备方法、含有它们的药物组合物以及它们在治疗中的用途。
• [EN] SUBSTITUTED N- [1-CYANO-2- (PHENYL) ETHYL] -2-AZABICYCLO [2.2.1] HEPTANE-3-CARBOXAMIDE INHIBITORS OF CATHEPSIN C<br/>[FR] N-[1-CYANO-2-(PHÉNYL)ÉTHYL]-2-AZABICYCLO[2.2.1]HEPTANE-3-CARBOXAMIDE SUBSTITUÉ UTILISÉ COMME INHIBITEUR DE LA CATHEPSINE C
  申请人：BOEHRINGER INGELHEIM INT

  公开号：WO2013041497A1

  公开（公告）日：2013-03-28

  This invention relates to N-1-cyano-2-(phenyl)ethyl)-2-azabicyclo[2.2.1]heptane-3-carboxamides of formula I, and their use as inhibitors of Cathepsin C, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of respiratory diseases.

  本发明涉及式I的N-1-氰基-2-(苯基)乙基)-2-氮杂双环[2.2.1]庚烷-3-羧酰胺，以及其作为Cathepsin C抑制剂的用途，含有这些化合物的药物组合物，以及将其用作治疗和/或预防呼吸道疾病的药物的方法。